Analysis of risk factors for cisplatin-induced nausea and vomiting during the extended overall phase in patients receiving cisplatin-based chemotherapy

○Rika Miyauchi

[31P-am413S] Analysis of risk factors for cisplatin-induced nausea and vomiting during the extended overall phase in patients receiving cisplatin-based chemotherapy

○Rika Miyauchi¹, Hiroshi Inano², Yoshihito Morimoto¹, Kanata Kitagawa², Akito Shibuya², Kozue Nakagomi², Tomohiro Ota², Yuri Anzo², Aiko Shono¹, Masayoshi Hirohara¹, Katsuya Otori^2,3, Kazuhiro Watanabe¹ (1. Showa. Pharm. Univ., 2. Dept. Pharm., Kitasato. Univ. Hosp., 3. Kitasato Univ. Sch. of Pharm.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[31P-am] Clinical Pharmacy

[31P-am413S] Analysis of risk factors for cisplatin-induced nausea and vomiting during the extended overall phase in patients receiving cisplatin-based chemotherapy

Password